Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2525 Views
-
Last post by NHE
-
- 6 Replies
- 7148 Views
-
Last post by ElliotB
-
- 0 Replies
- 1412 Views
-
Last post by NHE
-
- 0 Replies
- 3745 Views
-
Last post by NHE
-
- 1 Replies
- 1138 Views
-
Last post by NHE
-
- 1 Replies
- 1686 Views
-
Last post by NHE
-
- 11 Replies
- 3523 Views
-
Last post by NHE
-
- 0 Replies
- 3450 Views
-
Last post by NHE
-
- 0 Replies
- 1599 Views
-
Last post by NHE